Developed a dual-enzyme cascade system integrating iridium single-atom nanozymes with glucose oxidase, optimizing hydrogen peroxide production, acidity, and temperature within the tumor ...
Final results of a phase 2 trial of cabozantinib plus nivolumab (CaboNivo) in patients with non–clear cell renal cell carcinoma (nccRCC). This is an ASCO Meeting Abstract from the 2026 ASCO Annual ...
Developed a dual-enzyme cascade system integrating iridium single-atom nanozymes with glucose oxidase, optimizing hydrogen peroxide production, acidity, and temperature within the tumor ...
The goal of most anti-cancer approaches, including chemotherapy, radiation, immunotherapies, targeted therapies, and bone ...
Despite advances in cancer treatment, some tumors recur years or even decades after the initial response to therapy. Researchers attribute many of these late recurrences to dormant disseminated tumor ...
Development of payload-resistant human ovarian cancer cell lines to better understand antibody-drug conjugate sequencing and resistance mechanisms. YL205, a novel anti-Napi2b antibody drug conjugate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results